Assessment of the Analgesic Effects of PF-05089771 and Pregabalin in Healthy Volunteers Using Evoked Pain Endpoints

NCT02349607 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-05089771 300mg
DRUG: PF-05089771 300 mg + pregabalin 300 mg
DRUG: Placebo
DRUG: pregabalin 300 mg
DRUG: ibuprofen 600 mg

Sponsor

Pfizer